Schwark W S
Department of Pharmacology, New York State College of Veterinary Medicine, Cornell University, Ithaca 14853.
J Anim Sci. 1992 Nov;70(11):3635-45. doi: 10.2527/1992.70113635x.
Drugs administered to neonatal food-producing animals (cattle, sheep, goats, swine) may exhibit significantly different pharmacokinetic/disposition characteristics than they do in adult animals of the same species. Undesirable consequences such as suboptimum therapeutic concentrations, toxic effects, and violative tissue residues may result if adult dosage regimens are employed in young animals. Using selected drugs as examples, this paper reviews factors that contribute to differences in drug disposition in newborn vs adult animals. Immaturity of mechanisms involved in drug absorption, especially from gastrointestinal and parenteral sites of administration, and of drug distribution to sites such as plasma proteins, adipose tissue, and fluid compartments are considered. The role of developmental changes in drug biotransformation in the liver and other tissues and the maturation of excretory mechanisms, primarily from the kidney, in the increased rate of drug clearance during maturation is described. Pharmacokinetic studies with specific drugs in the target species are an important approach to establishing rational drug use in immature food-producing animals.
给新生的食用动物(牛、羊、山羊、猪)使用的药物,其药代动力学/处置特征可能与同一物种的成年动物有显著差异。如果对幼龄动物采用成年动物的给药方案,可能会导致诸如治疗浓度不理想、毒性作用和组织残留超标等不良后果。本文以选定的药物为例,综述了导致新生动物与成年动物药物处置差异的因素。文中考虑了药物吸收机制(尤其是从胃肠道和非肠道给药部位吸收)以及药物向血浆蛋白、脂肪组织和体液腔室等部位分布的不成熟性。描述了肝脏和其他组织中药物生物转化的发育变化以及排泄机制(主要是肾脏排泄机制)的成熟在成熟过程中药物清除率增加方面所起的作用。对目标物种进行特定药物的药代动力学研究是确定在未成熟食用动物中合理用药的重要方法。